Merck Manual

Please confirm that you are a health care professional

Loading

Cavernous Sinus Thrombosis

By

James Garrity

, MD, Mayo Clinic College of Medicine

Last full review/revision Jun 2020| Content last modified Jun 2020
Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version

Cavernous sinus thrombosis is a very rare, typically septic thrombosis of the cavernous sinus, usually caused by nasal furuncles or bacterial sinusitis. Symptoms and signs include pain, proptosis, ophthalmoplegia, vision loss, papilledema, and fever. Diagnosis is confirmed by CT or MRI. Treatment is with IV antibiotics. Complications are common, and prognosis is poor.

Etiology

The cavernous sinuses are trabeculated sinuses located at the base of the skull that drain venous blood from facial veins. Cavernous sinus thrombosis is an extremely rare complication of common facial infections, most notably nasal furuncles (50%), sphenoidal or ethmoidal sinusitis (30%), and dental infections (10%). Most common pathogens are Staphylococcus aureus (70%), followed by Streptococcus species; anaerobes are more common when the underlying condition is dental or sinus infection.

Thrombosis of the lateral sinus (related to mastoiditis) and thrombosis of the superior sagittal sinus (related to bacterial meningitis) occur but are rarer than cavernous sinus thrombosis.

Pathophysiology

The 3rd, 4th, and 6th cranial nerves and the ophthalmic and maxillary branches of the 5th cranial nerve are adjacent to the cavernous sinus and are commonly affected in cavernous sinus thrombosis. Complications of cavernous sinus thrombosis include meningoencephalitis, brain abscess, stroke, blindness, and pituitary insufficiency.

Symptoms and Signs

Initial symptoms of cavernous sinus thrombosis are progressively severe headache or facial pain, usually unilateral and localized to retro-orbital and frontal regions. High fever is common. Later, ophthalmoplegia (typically the 6th cranial nerve in the initial stage), proptosis, and eyelid edema develop and often become bilateral. Facial sensation may be diminished or absent. Decreased level of consciousness, confusion, seizures, and focal neurologic deficits are signs of central nervous system (CNS) spread. Patients with cavernous sinus thrombosis may also have anisocoria or mydriasis (3rd cranial nerve dysfunction), papilledema, and vision loss.

Diagnosis

  • MRI or CT

Cavernous sinus thrombosis is often misdiagnosed because it is rare. It should be considered in patients who have signs consistent with orbital cellulitis. Features that distinguish cavernous sinus thrombosis from orbital cellulitis include cranial nerve dysfunction, bilateral eye involvement, and mental status changes.

Diagnosis is based on neuroimaging. MRI is the better study, but CT is also helpful. Useful adjunct testing may include blood cultures and lumbar puncture.

Prognosis

Mortality is 30% in all patients with cavernous sinus thrombosis and 50% in those with underlying sphenoid sinusitis. An additional 30% develop serious sequelae (eg, ophthalmoplegia, blindness, disability due to stroke, pituitary insufficiency), which may be permanent.

Treatment

  • IV high-dose antibiotics

  • Sometimes corticosteroids

Initial antibiotics for patients with cavernous sinus thrombosis include nafcillin or oxacillin 1 to 2 g every 4 to 6 hours combined with a 3rd-generation cephalosporin (eg, ceftriaxone 1 g every 12 hours). In areas where methicillin-resistant S. aureus is prevalent, vancomycin 1 g IV every 12 hours should be substituted for nafcillin or oxacillin. A drug for anaerobes (eg, metronidazole 500 mg every 8 hours) should be added if an underlying sinusitis or dental infection is present.

In cases with underlying sphenoid sinusitis, surgical sinus drainage is indicated, especially if there is no clinical response to antibiotics within 24 hours.

Secondary treatment for cavernous sinus thrombosis may include corticosteroids (eg, dexamethasone 10 mg IV or orally every 6 hours) for cranial nerve dysfunction; anticoagulation is controversial because most patients respond to antibiotics, and adverse effects may exceed benefits.

More Information

Drugs Mentioned In This Article

Drug Name Select Trade
FLAGYL
OZURDEX
ROCEPHIN
VANCOCIN
NALLPEN IN PLASTIC CONTAINER
BACTOCILL IN PLASTIC CONTAINER
Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
Professionals also read

Also of Interest

Videos

View All
Glaucoma
Video
Glaucoma
Inside the eye are two fluid-filled chambers. Intraocular fluid, or eye fluid, is responsible...

SOCIAL MEDIA

TOP